CODEXIS, INC. CHANGE OF CONTROL SEVERANCE AGREEMENTChange of Control Severance Agreement • November 4th, 2022 • Codexis, Inc. • Industrial organic chemicals • California
Contract Type FiledNovember 4th, 2022 Company Industry JurisdictionThis Change of Control Severance Agreement (the “Agreement”) is made and entered into by and between Kevin Norrett (the “Executive”) and Codexis, Inc., a Delaware corporation (the “Company”), effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”).
Employment AgreementEmployment Agreement • November 4th, 2022 • Codexis, Inc. • Industrial organic chemicals • California
Contract Type FiledNovember 4th, 2022 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), dated as of August 9, 2022 (the “Effective Date”), is made by and between Codexis, Inc., a Delaware corporation (the “Company”), and Stephen Dilly, MBBS, Ph.D. (the “Executive” and, together with the Company, the “Parties”).
TRANSITION AND SEPARATION AGREEMENTTransition and Separation Agreement • November 4th, 2022 • Codexis, Inc. • Industrial organic chemicals • California
Contract Type FiledNovember 4th, 2022 Company Industry JurisdictionThis Transition and Separation Agreement (the “Agreement”) by and between John Nicols (“Executive”) and Codexis, Inc., a Delaware corporation (the “Company”), is made effective as of the eighth day following the date Executive signs this Agreement (the “Effective Date”) with reference to the following facts:
ENZYME SUPPLY AGREEMENTEnzyme Supply Agreement • November 4th, 2022 • Codexis, Inc. • Industrial organic chemicals • New York
Contract Type FiledNovember 4th, 2022 Company Industry JurisdictionTHIS ENZYME SUPPLY AGREEMENT, including the exhibits attached hereto (the “Agreement”), effective as of October 30, 2021 (the “Effective Date”), is made and entered into by and between Codexis, Inc., a Delaware corporation, having a place of business at 200 Penobscot Drive, Redwood City, California 94063, United States of America (“Codexis”), and Pfizer Ireland Pharmaceuticals, an Irish corporation, with its principal place of business at Operations Support Group, Ringaskiddy, Cork, Ireland, and its Affiliates (“Pfizer”). Codexis and Pfizer each may be referred to herein individually as a “Party,” or collectively as the “Parties.”